John T. Wilson

John T. Wilson

Vanderbilt University

H-index: 30

North America-United States

About John T. Wilson

John T. Wilson, With an exceptional h-index of 30 and a recent h-index of 23 (since 2020), a distinguished researcher at Vanderbilt University, specializes in the field of biomaterials, drug delivery, immunotherapy, extracellular vesicles.

His recent articles reflect a diverse array of research interests and contributions to the field:

STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy

Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer

Controlling the STING pathway to improve immunotherapy

Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

Covalent Polymer‐RNA Conjugates for Potent Activation of the RIG‐I Pathway

Multiparametric Single-Vesicle Flow Cytometry Resolves Extracellular Vesicle Heterogeneity and Reveals Selective Regulation of Biogenesis and Cargo Distribution

STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of Inflammatory Diseases

John T. Wilson Information

University

Position

Assistant Professor

Citations(all)

3608

Citations(since 2020)

2263

Cited By

2050

hIndex(all)

30

hIndex(since 2020)

23

i10Index(all)

48

i10Index(since 2020)

41

Email

University Profile Page

Vanderbilt University

Google Scholar

View Google Scholar Profile

John T. Wilson Skills & Research Interests

biomaterials

drug delivery

immunotherapy

extracellular vesicles

Top articles of John T. Wilson

Title

Journal

Author(s)

Publication Date

STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy

bioRxiv

Taylor L Sheehy

Alexander J Kwiatkowski

Karan Arora

Blaise R Kimmel

Jacob A Schulman

...

2024/3/27

Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer

Cancer Research Communications

Elizabeth C Wescott

Xiaopeng Sun

Paula Gonzalez-Ericsson

Ann Hanna

Brandie C Taylor

...

2024/4/24

Controlling the STING pathway to improve immunotherapy

Nature Nanotechnology

John T Wilson

2024/3/25

Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy

ACS nano

Lihong Wang-Bishop*

Mohamed Wehbe*

Lucinda E Pastora*

Jinming Yang

Blaise R Kimmel

...

2024/4/23

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

ACS nano

Jessalyn J Baljon

Alexander J Kwiatkowski

Hayden M Pagendarm

Payton T Stone

Amrendra Kumar

...

2024/2/22

Covalent Polymer‐RNA Conjugates for Potent Activation of the RIG‐I Pathway

Advanced Healthcare Materials

Christian R Palmer

Lucinda E Pastora

Blaise R Kimmel

Hayden M Pagendarm

Alexander J Kwiatkowski

...

2024/4/22

Multiparametric Single-Vesicle Flow Cytometry Resolves Extracellular Vesicle Heterogeneity and Reveals Selective Regulation of Biogenesis and Cargo Distribution

ACS nano

Ariana K von Lersner

Fabiane Fernandes

Patricia Midori Murobushi Ozawa

Marques Jackson

Matthieu Masureel

...

2024/4/5

STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of Inflammatory Diseases

Lucinda E Pastora

Neeraj S Namburu

Karan Arora

Plamen P Christov

John T Wilson

2024/4/2

STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy

Science Immunology

Lihong Wang-Bishop*

Blaise R Kimmel*

Verra M Ngwa

Matthew Z Madden

Jessalyn J Baljon

...

2023/5/5

IQGAP2 regulates blood-brain barrier immune dynamics

bioRxiv

Ketaki A Katdare

Andrew Kjar

Natasha M O’Brown

Emma H Neal

Alexander G Sorets

...

2023/2/8

Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction

Cancer Research Communications

David C Florian

Natalie E Bennett

Mateusz Odziomek

Jessalyn J Baljon

Mohamed Wehbe

...

2023/2/8

Culture conditions greatly impact the levels of vesicular and extravesicular Ago2 and RNA in extracellular vesicle preparations

Journal of Extracellular Vesicles

Lizandra Jimenez

Bahnisikha Barman

Youn Jae Jung

Lauren Cocozza

Evan Krystofiak

...

2023/10/26

Engineering endosomolytic nanocarriers of diverse morphologies using confined impingement jet mixing

Nanoscale

Hayden M Pagendarm

Payton T Stone

Blaise R Kimmel

Jessalyn J Baljon

Mina H Aziz

...

2023

A Nanoparticle RIG-I Agonist for Cancer Immunotherapy

bioRxiv

Lihong Wang-Bishop

Mohamed Wehbe

Lucinda E Pastora

Jinming Yang

Kyle M Garland

...

2023

Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy

Cancer Research Communications

Kyle M Garland

Alexander J Kwiatkowski

John T Tossberg

Philip S Crooke III

Thomas M Aune

...

2023/9/8

Dual-Responsive Glycopolymers for Intracellular Codelivery of Antigen and Lipophilic Adjuvants

Molecular pharmaceutics

Judith De Mel

Mehjabeen Hossain

Oluwaseyi Shofolawe-Bakare

Sk Arif Mohammad

Emily Rasmussen

...

2022/11/14

Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy

Kyle M Garland

Taylor L Sheehy

John T Wilson

2022/2/2

EV Fingerprinting: Resolving extracellular vesicle heterogeneity using multi-parametric flow cytometry

bioRxiv

Ariana K von Lersner

Fabiane CL Fernandes

Patricia MM Ozawa

Sierra M Lima

Tatyana Vagner

...

2022/11/11

Graft copolymers, methods of forming graft copolymers, and methods of use thereof

2022/1/13

A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination

Scientific reports

Naveenchandra Suryadevara

Amrendra Kumar

Xiang Ye

Meredith Rogers

John V Williams

...

2022/11/9

See List of Professors in John T. Wilson University(Vanderbilt University)